+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells



Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells



World Journal of Gastroenterology 24(21): 2236-2246



Gastric cancer (GC), with its high incidence and mortality rates, is a highly fatal cancer that is common in East Asia particularly in China. Its recurrence and metastasis are the main causes of its poor prognosis. Circulating tumor cells (CTCs) or other blood biomarkers that are released into the circulating blood stream by tumors are thought to play a crucial role in the recurrence and metastasis of gastric cancer. Therefore, the detection of CTCs and other blood biomarkers has an important clinical significance; in fact, they can help predict the prognosis, assess the staging, monitor the therapeutic effects and determine the drug susceptibility. Recent research has identified many blood biomarkers in GC, such as various serum proteins, autoantibodies against tumor associated antigens, and cell-free DNAs. The analysis of CTCs and circulating cell-free tumor DNA (ctDNA) in the peripheral blood of patients with gastric cancer is called as liquid biopsy. These blood biomarkers provide the disease status for individuals and have clinical meaning. In this review, we focus on the recent scientific advances regarding CTCs and other blood biomarkers, and discuss their origins and clinical meaning.

(PDF emailed within 0-6 h: $19.90)

Accession: 065437953

Download citation: RISBibTeXText

PMID: 29881233

DOI: 10.3748/wjg.v24.i21.2236


Related references

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Journal of Experimental and Clinical Cancer Research 37(1): 213, 2018

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy. International Journal of Molecular Sciences 18(5), 2018

The Prognostic Roles of Pretreatment Circulating Tumor Cells, Circulating Cancer Stem-Like Cells, and Programmed Cell Death-1 Expression on Peripheral Lymphocytes in Patients with Initially Unresectable, Recurrent or Metastatic Head and Neck Cancer: An Exploratory Study of Three Biomarkers in One-time Blood Drawing. Cancers 11(4), 2019

Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer. Cancer Letters 346(1): 24-33, 2014

Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy. Pharmacogenomics 17(3): 183-186, 2016

Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study. Investigational New Drugs 35(3): 334-344, 2017

Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA. Tumour Biology 40(5): 1010428318776169, 2018

Circulating tumour cells is a promising prognostic and predictive marker of gastric cancer. Ugeskrift for Laeger 176(32): 1490-1493, 2016

The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer. Oncologist 2019, 2019

Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer. International Journal of Cancer 135(3): 731-741, 2014

The role of circulating tumor cells in metastatic breast cancer: prognostic and predictive value. Molecular Biology Reports 2018, 2018

Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker. Journal of Patient-Centered Research and Reviews 1(2): 85-92, 2015

Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study. Bmc Cancer 17(1): 384, 2018

Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. Annals of Oncology 23(11): 2937-2942, 2013

Detection of circulating tumor cells in breast cancer patients: prognostic predictive role. Asian Pacific Journal of Cancer Prevention 14(3): 1601-1607, 2014